Board approves up to Rs 250 crore preferential issue of convertible warrants

Fund Raising View source PDF Explain this filing

AHCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.3%Reaction day

₹30.66

prior close

₹30.97

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-6.0% vs market

Pharmaceuticals peers, median of 172sector+0.0%-5.3% vs sector

On the reaction day the stock moved 6.0 pts less than Nifty Microcap 250 and 5.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-3.2

10m

-3.2

15m

-3.9

30m

-4.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.3+0.7-6.0+0.0-5.3

Next day

-10.0-1.0-9.1-0.8-9.2

-12.0-0.3-11.8-0.6-11.4

-12.2-1.9-10.3-1.9-10.3

-16.4-4.5-11.9-3.5-12.9

-20.6-5.5-15.1-4.4-16.2

-19.1-7.3-11.8-4.3-14.8

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved raising up to Rs 250 crore by issuing convertible warrants on a preferential basis to 2 promoters and 2 public investors. Each warrant converts into 1 equity share of Rs 2 face value. Allottees pay 25 percent upfront and 75 percent on conversion within 18 months, else the amount is forfeited. Issue price is yet to be fixed at a later board meeting.

Likely market impact

Potential dilution for existing shareholders. Promoter participation signals confidence. Final issue price and shareholder approval yet to come.